Search for a full or partial Catalog Number, CAS Number or description
CAS Number: 7447-41-8
Product Catalog
93-0313
Lithium › Lithium chloride, 99% (ACS)| CAS Number: | 7447-41-8 |
| MDL Number: | MFCD00011078 |
| Molecular Formula: | ClLi |
| Molecular Weight: | 42.39 |
| Chemical Formula: | LiCl |
| Color and Form: | white pwdr. |
| Note: |
Stability: hygroscopic
Physical Characteristics: melting point 614°C, boiling point 1325-1360°C, density 2.068
| SECTION 1: Product Identification | |
|---|---|
| Chemical Name: | Lithium chloride, 99% (ACS) |
| Product Number: | 93-0313 |
| CAS Registry Number: | 7447-41-8 |
| Formula: | LiCl |
| EINECS Number: | 231-212-3 |
| Chemical Family: | metal halide |
| Synonym: | Lithium monochloride |
| SECTION 2: Composition and Information on Ingredients | ||||
|---|---|---|---|---|
| Ingredient | CAS Number | Percent | ACGIH (TWA) | OSHA (PEL) |
| Title Compound | 7447-41-8 | 100 | no data | no data |
| SECTION 3: Hazards Identification | |
|---|---|
| Emergency Overview: | Harmful in contact with skin and if swallowed. Irritating to eyes, skin, respiratory tract. May cause harm to the unborn child and breastfed babies. Possible risk of irreversible effects. |
| Primary Routes of Exposure: | Ingestion, Inhalation of dust. |
| Eye Contact: | Causes slight to mild irritation of the eyes. |
| Skin Contact: | Causes slight to mild irritation of the skin. |
| Inhalation: | Irritating to the nose, mucous membranes and respiratory tract. |
| Ingestion: | Ingestion may lead to dizziness, abdominal cramps, vomiting, bloody diarrhea, weakness, and convulsions. |
| Acute Health Effects: | Irritating to skin, eyes and respiratory tract. Harmful in contact with skin and if swallowed. May cause harm to the unborn child and breastfed babies. |
| Chronic Health Effects: | Prolonged exposure to lithium salts may cause kidney damage. Possible risk of impaired fertility. |
| NTP: | No |
| IARC: | No |
| OSHA: | No |
| SECTION 4: First Aid Measures | |
|---|---|
| Eye Exposure: | Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need assistance in keeping their eye lids open. Get immediate medical attention. |
| Skin Exposure: | Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if irritation persists. |
| Inhalation: | Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance. |
| Ingestion: | Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce vomiting only if directed by medical personnel. |
| SECTION 5: Fire Fighting Measures | |
|---|---|
| Flash Point: | not applicable |
| Autoignition Temperature: | none |
| Explosion Limits: | none |
| Extinguishing Medium: | None. Material is non-flammable. |
| Special Fire Fighting Procedures: | No special fire fighting procedures required. |
| Hazardous Combustion and Decomposion Products: | none |
| Unusual Fire or Explosion Hazards: | No unusual fire or explosion hazards. |
| SECTION 6: Accidental Release Measures | |
|---|---|
| Spill and Leak Procedures: | To avoid raising dust, small spills may be mixed with diatomaceous earth, sand, vermiculite or other suitable inert material and swept up. |
| SECTION 7: Handling and Storage | |
|---|---|
| Handling and Storage: | Store solid in a tightly sealed container away from moisture. Handle under a dry atmosphere of air or nitrogen. Prolonged exposure to the atmosphere may degrade the product. |
| SECTION 8: Exposure Controls and Personal Protection | |
|---|---|
| Eye Protection: | Always wear approved safety glasses when handling a chemical substance in the laboratory. |
| Skin Protection: | Wear protective clothing and gloves. Consult with glove manufacturer to determine the proper type of glove. |
| Ventilation: | Material may form a fine dust. If possible, handle the material in an efficient fume hood. |
| Respirator: | If in form of fine dust and ventilation is not available a respirator should be worn. The use of respirators requires a Respirator Protection Program to be in compliance with 29 CFR 1910.134. |
| Additional Protection: | No additional protection required. |
| SECTION 9: Physical and Chemical Properties | |
|---|---|
| Color and Form: | white pwdr. |
| Molecular Weight: | 42.39 |
| Melting Point: | 614°C |
| Boiling Point: | 1325-1360°C |
| Vapor Pressure: | no data |
| Specific Gravity: | 2.068 |
| Odor: | none |
| Solubility in Water: | 63.7 g/100cc (0°C) |
| SECTION 10: Stability and Reactivity | |
|---|---|
| Stability: | hygroscopic |
| Hazardous Polymerization: | no hazardous polymerization |
| Conditions to Avoid: | contact with moisture |
| Incompatibility: | none |
| Decomposition Products: | none |
| SECTION 11: Toxicological Information | |
|---|---|
| RTECS Data: | Administration onto the skin (rabbit); Standard Draize test: 500 mg/24H. Administration into the eye (rabbit); Standard Draize test: 100 mg/24H. Oral (human); LDLo: 200 mg/kg/3D. Oral (human); TDLo: 243 mg/kg/13D. Oral (rat); LD50: 526 mg/kg. Intraperitoneal (rat); LD50: 514 mg/kg. Subcutaneous (rat); LD50: 499 mg/kg. Intracerebral (rat); LD50: 4800 ug/kg. Intraperitoneal (cat); LD50: 492 mg/kg. Oral (rabbit); LD50: 800 mg/kg. Oral (rat); TDLo: 712 mg/kg/1W-C. Intraperitoneal (mouse); TDLo: 882 mg/kg/7D-I. Intraperitoneal (rat); TDLo: 41360 mg/kg. Human Lymphocyte; DNA inhibition: 50 mg/L. Human HeLe cell; DNA inhibition: 70 nmol/L. |
| Carcinogenic Effects: | Insufficient data |
| Mutagenic Effects: | Negative data |
| Tetratogenic Effects: | Reproductive effector |
| SECTION 12: Ecological Information | |
|---|---|
| Ecological Information: | No information available |
| SECTION 13: Disposal Considerations | |
|---|---|
| Disposal: | Dispose of according to local, state and federal regulations. |
| SECTION 14: Transportation | |
|---|---|
| Shipping Name (CFR): | Non-hazardous |
| Hazard Class (CFR): | NA |
| Additional Hazard Class (CFR): | NA |
| Packaging Group (CFR): | NA |
| UN ID Number (CFR): | NA |
| Shipping Name (IATA): | Non-hazardous |
| Hazard Class (IATA): | NA |
| Additional Hazard Class (IATA): | NA |
| Packaging Group (IATA): | NA |
| UN ID Number (IATA): | NA |
| SECTION 15: Regulatory Information | |
|---|---|
| TSCA: | Listed in the TSCA inventory. |
| SARA (Title 313): | Title compound not listed. |
| Second Ingredient: | none |
| Third Ingredient: | none |
| SECTION 16: Other Information | |
|---|---|
| Disclaimer: | The information herein is believed to be accurate and reliable as of the date compiled. However, Strem Chemicals, Inc. makes no representation, warranty, or guarantee of any kind with respect to the information contained in this document or any use of the product based on this information. |
| Preparation Date: | 6/11/2001 |
| Revision Date: | 12/14/2011 |
